|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chang J, Denham L, Dong EK, Malek K and
Lum SS: Trends in the diagnosis of phyllodes tumors and
fibroadenomas before and after release of WHO classification
standards. Ann Surg Oncol. 25:3088–3095. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Krings G, Bean GR and Chen YY:
Fibroepithelial lesions: The WHO spectrum. Semin Diagn Pathol.
34:438–452. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tan PH, Ellis I, Allison K, Brogi E, Fox
SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, et al: The
2019 WHO classification of tumours of the breast. Histopathology.
77:181–185. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tan BY, Acs G, Apple SK, Badve S,
Bleiweiss IJ, Brogi E, Calvo JP, Dabbs DJ, Ellis IO, Eusebi V, et
al: Phyllodes tumours of the breast: A consensus review.
Histopathology. 68:5–21. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kuo CY, Lin SH, Lee KD, Cheng SJ, Chu JS
and Tu SH: Transcatheter arterial chemoembolization improves the
resectability of malignant breast phyllodes tumor with angiosarcoma
component: A case report. BMC Surg. 19(100)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gradishar WJ, Anderson BO, Balassanian R,
Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A,
Giordano SH, et al: Breast cancer, version 4.2017, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
16:310–320. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mitus J, Reinfuss M, Mitus JW, Jakubowicz
J, Blecharz P, Wysocki WW and Skotnicki P: Malignant phyllodes
tumor of the breast: Treatment and prognosis. Breast J. 20:639–644.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hashimoto K, Mimura H, Arai Y, Doi M,
Kojima Y, Tsugawa K and Nakajima Y: Successful preoperative
chemoembolization in the treatment of a giant malignant phyllodes
tumor. Cardiovasc Intervent Radiol. 39:1070–1075. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Moten AS and Goldberg AJ: Malignant
phyllodes tumors of the breast: Association between race, clinical
features, and outcomes. J Surg Res. 239:278–283. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Atalay C, Kınaş V and Çelebioğlu S:
Analysis of patients with phyllodes tumor of the breast. Ulus
Cerrahi Derg. 30:129–132. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dillon MF, Quinn CM, McDermott EW,
O’Doherty A, O’Higgins N and Hill ADK: Needle core biopsy in the
diagnosis of phyllodes neoplasm. Surgery. 140:779–784.
2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Moriarty JM, Xing MZ and Loh CT: Particle
embolization to control life-threatening hemorrhage from a
fungating locally advanced breast carcinoma: A case report. J Med
Case Rep. 6(186)2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Corvino F, Giurazza F, Cangiano G,
Cavaglià E, Amodio F, Magistris GD, Corvino A and Niola R: Safety
and effectiveness of transcatheter embolization in the treatment of
internal mammary artery injuries. Radiol Med. 123:369–377.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Aksoy Ş, Akçe B, Kiliçkesmez Ö, Gürsü RU,
Çakır MS, Nazlı MA and Aren A: Transcatheter arterial embolization
for controlling severe bleeding from recurrent locally-advanced
breast cancer. J Breast Health. 12:137–140. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Leung JWT, Gotway MB and Sickles EA:
Preoperative embolization of vascular phyllodes tumor of the
breast. AJR Am J Roentgenol. 184 (Suppl 3):S115–S117.
2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gulbahce N, Magbanua MJM, Chin R, Agarwal
MR, Luo XH, Liu J, Hayden DM, Mao Q, Ciotlos S, Li ZY, et al:
Quantitative whole genome sequencing of circulating tumor cells
enables personalized combination therapy of metastatic cancer.
Cancer Res. 77:4530–4541. 2017.PubMed/NCBI View Article : Google Scholar
|
